原标题：宝石花集团视察易特科（前海安测）“AI医疗云”

2019年4月11日，宝石花医疗健康投资控股集团有限公司董事长汪世宏先生、常务副董事长王晓滨女士等宝石花医疗集团高管团队近30人在华为云医疗总监张绍蔚先生、华为（中石油）客户总监戴启家先生的介绍陪同下，莅临易特科集团（前海安测）深圳总部考察“AI+健康云+养老云+医疗云”技术创新及产业化。易特科集团董事长兼CEO张贯京先生、副董事长肖应芬女士等核心团队全程陪同考察！

宝石花医疗健康集团考察团在张贯京董事长的陪同下，首先参观了我司智慧医疗实验室、研发中心、产品展厅、文化展厅。

在智慧医疗实验室，张贯京董事长向宝石花集团考察团介绍了我司与诺奖科学家Edvard I. Moser教授和Craig C. Mello教授合作的智慧医疗诺奖实验室项目，以及集团在中医AI辅助诊断大数据平台、AI医疗云平台、AI体检 慢病筛查大数据平台、AI肿瘤筛查和辅助诊断大数据平台的研发创新，考察团听取汇报后夸赞易特科（前海安测）在“AI+医疗+健康+养老”的技术应用有着突出的创新思路和发展前景。

在研发中心，考察团重点视察了集团3000多项专利技术的科研转化，重点考察了我司获得中国专利优秀奖等重点专利技术创新，考察团夸赞易特科集团专利事业不断发展，专利管理和服务体系成绩喜人。

在产品展厅，我司研发团队向考察团演示了安测健康智能一体机、中医四诊仪、体质辨识仪、治未病服务系统、慢病管理系统等产品和服务，张贯京董事长介绍道，我司旗下产品自助健康监测智能一体机和安测AI+慢性病管理平台入选国家工信部、国家民政部、国家卫健委联合推荐的《智慧健康养老产品及服务推广目录》，慢性病管理系统研发及产业化项目荣获深圳市科技进步奖二等奖。考察团还对集团产品市场应用、科研团队、产学研合作、荣誉概况等进行了详细的深入的考察。

座谈会上，易特科集团董事长兼CEO张贯京先生首先对宝石花团队及华为云团队的视察指导及合作支持表示衷心感谢，并向与会代表介绍了集团的发展情况，着重讲解了集团近年来取得的创新成果。张贯京董事长表示，创新是易特科（前海安测）发展壮大的核心竞争力，与华为云全面战略合作，引进了华为云的AI研发平台（GPU和ModelArts)/算法算力以及知识图谱工具，我司研发团队正重点完善AI医疗云、AI慢病云、AI中医云、AI肿瘤云的技术研发，进一步深化AI-TCM、AI-CAD、AI-MRI等高端智能影像诊断系统研发创新和产业化。我们正通过科技研发、产学研合作等方式，将公司打造成一家走在时代前沿、走在行业前列的技术提供商，成为智慧医疗行业的领跑者！我司正通过华为云的平台向全国各地医卫机构提供AI医疗信息化的服务。作为华为云的解决方案提供商、行销合作伙伴、客户、供应商、研发合作伙伴以及华为云AI俱乐部成员，易特科集团（前海安测）与华为云的合作正在全面深化，也正在与华为云一起竭诚为更多的医疗机构提供专业的服务。张贯京董事长还表示，易特科集团将与华为云一起，愿意为宝石花集团成长为世界一流医疗集团、世界一流医养集团贡献自己的技术力量，为提升临床医学和健康服务的效率、效力和效益而提供技术保障。

宝石花医疗健康投资控股集团有限公司董事长汪世宏先生在讲话中肯定了易特科集团技术创新、专利创新的先锋示范作用，同时表示易特科集团的创新精神与宝石花医疗集团整合全球先进医疗资源，助力中国未来医改的发展理念不谋而合，双方有广泛的合作基础与空间，希望日后双方在人才、技术方面加强经验交流，加深彼此了解和深化彼此友谊！汪世宏董事长还表示，宝石花集团力争成为世界一流的医疗集团、世界一流的医养集团，希望能够与华为、易特科集团这样的高科技公司合作，通过科技创新，提升临床医学服务和健康管理的能力和水平。汪世宏董事长和王晓滨副董事长还对于与易特科集团（前海安测）战略层面的合作表示支持！

华为云医疗总监张绍蔚先生发言时提到，易特科集团（前海安测）与华为云有着深入的战略合作，是华为云10家AI俱乐部成员之一，希望华为云、易特科集团、宝石花医疗健康集团日后在数字医疗健康、人工智能等领域加强沟通交流，以战略性、前瞻性、系统性思维合作促进发展，共推智慧医疗创新发展，更好地服务于人民健康！华为云医疗总监张绍蔚先生还表示，华为云将以客户为中心，与合作伙伴（易特科集团）一起，共同努力，竭诚为宝石花集团等客户提供高水平的专业服务。

通过实地查看、听取汇报和座谈交流的方式，宝石花医疗健康集团考察团一行对我司科技创新、智慧医疗项目、专利技术、产品创新、乡等情况给予了高度评价，双方首次会谈圆满成功，更为双方今后的合作打下坚实的基础！

易特科董事长兼CEO张贯京、副董事长兼MD肖应芬、CTO葛新科、高级副总裁王海荣、总工程师高伟明、副总裁唐小浪、副总裁宋若东、副总工程师张红治、副总工程师周亮、投资经理霍建新、售前经理赵康府、总裁助理陈匆、总裁助理杨艳铭、宣传部部长丁亮、宣传部高级工程师易勇、宣传部经理张夜雨等易特科集团团队；

宝石花医疗健康投资控股集团有限公司董事长汪世宏、常务副董事长王晓滨、副总裁张辉、副总裁关铁、宝石花医疗资产投资有限公司总经理马德库、宝石花(辽宁)医疗健康管理有限公司总经理王旸、吉林宝石花吉油医疗健康管理有限公司总经理石文杰、四川宝石花医疗管理有限公司常务副总经理杨世平，兰州宝石花医疗管理有限公司总经理孙兴昌、宝石花长庆医疗健 康投资管理有限公司总经理席建堂、辽阳宝石花医疗管理有限公司总经理朱文杰、宝石花东方医疗健康管理有限公司总经理晁志涛、新疆宝石花医疗健康管理有限公司总经理于少俊、葫芦岛宝石花医疗健康管理有限公司总经理赵连东、宝石花医疗健康投资控股集团有限公司创新与信息化部信息副总监陈宏立、宝石花医疗信息技术有限公司副总经理阳煜东，宝石花医疗信息技术有限公司销售经理郭良、宝石花徐军等宝石花医疗集团团队；

华为云医疗总监张绍蔚、华为中石油大客户部客户总监戴启家、华为孔珍珍等华为云团队出席会议。

宝石花医疗集团简介：

宝石花医疗集团通过整合中石油集团相关医疗资产，形成拥有约10家三级医院，300余家医疗机构，营业收入约100亿元，管理床位约2万张，服务400多万石油职工家属，以及周边上千万居民的中国及至亚洲最大的医疗健康产业集团。宝石花医疗拟通过八大平台、三级发展的思路，整合全球先进医疗资源，助力中国未来医改发展。

Gem Flower Group inspects E-Techco (Qianhai AnyCheck) \"AI Medical Cloud\"

On April 11th, 2019, Mr. Wang Shihong, Chairman of Gem Flower Healthcare Investment Holding Group Co., Ltd., Ms. Wang Xiaobin, Executive Vice Chairman, and other senior management team of Gem Flower Healthcare, nearly 30 people in Huawei Cloud Medical Director Mr. Zhang Shaowei, Huawei (PetroChina) Accompanied by the introduction of Mr. Dai Qijia, the Director of the Client, he visited the Shenzhen Branch of E-Techco Group (Qianhai AnyCheck) to inspect the technological innovation and industrialization of “AI+Health Cloud+Pillage Cloud+Medical Cloud”. Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group, and Ms. Xiao Yingfen, Vice Chairman of the Board of Directors, accompanied the whole team to accompany them.

Accompanied by Chairman Zhang Guanjing, Gem Flower Healthcare Group visited the smart medical laboratory, research and development center, product exhibition hall and cultural exhibition hall.

In the Smart Medical Laboratory, Chairman Zhang Guanjing introduced to the Gem Flower Group delegation the wisdom medical Nobel Prize laboratory project that our company cooperated with the Nobel Prize-winning scientists Professor Edvard I. Moser and Professor Craig C. Mello, and the group assisted by Chinese medicine AI. Diagnose big data platform, AI medical cloud platform, AI physical examination chronic disease screening big data platform, AI tumor screening and auxiliary diagnosis big data platform research and development innovation, the delegation listened to the report and praised E-Techco (Qianhai AnyCheck) The technical application of “AI+Medical+Health+Support” has outstanding innovative ideas and development prospects.

In the R D center, the delegation focused on inspecting the scientific research transformation of more than 3,000 patent technologies of the group, focusing on the key patent technology innovations such as the China Patent Excellence Award, and the delegation praised the continuous development of the patent business of E-Techco Group, patent management and The service system scores are gratifying.

In the product exhibition hall, our research and development team demonstrated the products and services of Anzhen Health Integrated Intelligent Machine, Chinese Medicine Four Diagnosis Apparatus, Physical Fitness Analyzer, Treatment of Untreated Disease System, and Slow Disease Management System to the delegation. Zhang Guanjing introduced the chairman. Our self-service health monitoring intelligent integrated machine and safety test AI+ chronic disease management platform were selected into the “Smart Health Pension Products and Services Promotion Catalogue” jointly recommended by the Ministry of Industry and Information Technology, the Ministry of Civil Affairs and the National Health Care Committee, and the development and industrialization of chronic disease management systems. The project won the second prize of Shenzhen Science and Technology Progress Award. The delegation also conducted a detailed and in-depth study of the Group\'s product market applications, research teams, industry-university-research cooperation, and honors.

At the symposium, Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group, first expressed his heartfelt gratitude to the Gem Flower Team and the Huawei Cloud team for their inspection and cooperation and support, and introduced the development of the Group to the participants, focusing on the Group\'s recent development. The innovations achieved. Chairman Zhang Guanjing said that innovation is the core competitiveness of E-Techco (Qianhai AnyCheck), and has fully integrated strategic cooperation with Huawei Cloud, introducing Huawei Cloud\'s AI R D platform (GPU and ModelArts)/algorithm computing power and knowledge mapping tools. The R D team of our company is focusing on improving the technology research and development of AI medical cloud, AI chronic disease cloud, AI Chinese medicine cloud and AI tumor cloud, and further deepening the research and development innovation of high-end intelligent image diagnosis systems such as AI-TCM, AI-CAD and AI-MRI. Industrialization. We are making a company that is at the forefront of the times and a leader in the industry through technology research and development, industry-university-research cooperation, etc., and become the leader in the smart medical industry. Our company is providing AI medical information services to medical institutions across the country through Huawei\'s platform. As a solution provider, marketing partner, customer, supplier, R D partner and Huawei Cloud AI Club member of Huawei Cloud, the cooperation between E-Techco Group (Qianhai AnyCheck) and Huawei Cloud is deepening and is also being Huawei. Together with the cloud, we are dedicated to providing professional services to more medical institutions. Chairman Zhang Guanjing also said that E-Techco Group, together with Huawei Cloud, is willing to contribute to the growth of the Gem Flower Group as a world-class medical group and a world-class medical care group, in order to improve the efficiency and effectiveness of clinical medicine and health services. Provide technical support for efficiency.

In his speech, Mr. Wang Shihong, Chairman of Gem Flower Healthcare Investment Holding Group Co., Ltd. affirmed the pioneering role of E-Techco Group in technological innovation and patent innovation. He also expressed the innovative spirit of E-Techco Group and the integration of global advanced medical care with Gem Flower Healthcare. The resources and the development concept of China\'s future medical reform coincide, and both sides have extensive cooperation foundations and space. I hope that the two sides will strengthen exchanges of experience in talents and technologies in the future, and deepen mutual understanding and deepen mutual friendship! Chairman Wang Shihong also said that Gemstone Group strives to become a world-class medical group and a world-class medical care group. It hopes to cooperate with high-tech companies such as Huawei and E-Techco Group to enhance clinical medical services and health through technological innovation. The ability and level of management. Chairman Wang Shihong and Vice Chairman Wang Xiaobin also expressed support for the cooperation with E-Techco Group (Qianhai AnyCheck) strategic level!

Mr. Zhang Shaowei, Director of Huawei Cloud Medical, mentioned that E-Techco Group (Qianhai AnyCheck) and Huawei Cloud have in-depth strategic cooperation and are one of the members of Huawei Cloud 10 AI Club. They hope Huawei Cloud, E-Techco Group, Gems Hua Medical Health Group will strengthen communication and communication in the fields of digital medical health and artificial intelligence in the future, and promote cooperation with strategic, forward-looking and systematic thinking to promote the development of smart medical innovation and better serve the people\'s health! Mr. Zhang Shaowei, Director of Huawei Cloud Medical, also said that Huawei Cloud will be customer-centric and work together with partners (E-Techco Group) to provide high-level professional services to customers such as Gem Flower Group.

Through on-the-spot viewing, listening to reports and seminars, Gem Flower Healthcare Group delegation gave high praise to our company\'s scientific and technological innovation, smart medical projects, patent technology, product innovation, and township. The first meeting between the two sides was a complete success. It will lay a solid foundation for future cooperation between the two sides.

E-Techco Chairman and CEO Zhang Guanjing, Vice Chairman and MD Xiao Yingfen, CTO Ge Xinke, Senior Vice President Wang Hairong, Chief Engineer Gao Weiming, Vice President Tang Xiaolang, Vice President Song Ruodong, Chief Engineer Zhang Hongzhi, Deputy Chief Engineer Zhou Liang, Investment Manager Huo Jianxin, pre-sales manager Zhao Kangfu, president assistant Chen Xiu, president assistant Yang Yanming, propaganda department director Ding Liang, propaganda department senior engineer Yi Yong, propaganda department manager Zhang Yeyu and other E-Techco Group team; Gem Flower Healthcare Investment Holdings Chairman of the Group Co., Ltd. Wang Shihong, Executive Vice Chairman Wang Xiaobin, Vice President Zhang Hui, Vice President Guan Tie, General Manager of Gem Flower Medical Assets Investment Co., Ltd. Ma Deku, General Manager of Gem Flower (Liaoning) Medical Health Management Co., Ltd. Shi Wenjie, General Manager of Jilin Gem Flower Jiji Medical Health Management Co., Ltd., Yang Shiping, Executive Deputy General Manager of Sichuan Gem Flower Medical Management Co., Ltd., Sun Xingchang, General Manager of Lanzhou Gem Flower Medical Management Co., Ltd., Gem Flower Changqing Medical Health Investment Management Co., Ltd. Manager Xi Jiantang, Liaoyang Gem Flower Medical Management Co., Ltd. Manager Zhu Wenjie, General Manager of Gem Flower Oriental Medical Health Management Co., Ltd. Qi Zhitao, General Manager of Xinjiang Gem Flower Healthcare Management Co., Ltd. Yu Shaojun, General Manager of Huludao Gem Flower Healthcare Management Co., Ltd. Zhao Liandong, Gem Flower Healthcare Investment Holding Group Limited Chen Hongli, deputy director of information of the company\'s innovation and information technology department, Yang Yidong, deputy general manager of Gemshua Medical Information Technology Co., Ltd., Guo Liang, sales manager of Gemshua Medical Information Technology Co., Ltd., Gem Flower Xu Jun and other gemstone medical group; Huawei Cloud Zhang Shaowei, medical director, Dai Qijia, customer director of Huawei\'s major customers, and Huawei\'s Kong Zhenzhen, attended the meeting.

Introduction to Gem Flower Healthcare:

Gem Flower Healthcare has formed about 10 tertiary hospitals and more than 300 medical institutions through the integration of relevant medical assets of CNPC. The operating income is about 10 billion yuan, the number of beds is about 20,000, and the families of more than 4 million oil workers are served. China and the largest medical and health industry group in Asia with tens of millions of residents. Gem Flower Medical intends to integrate the world\'s advanced medical resources through the eight platforms and three-level development ideas to help China\'s future medical reform and development.返回搜狐，查看更多

责任编辑：